Timuçin Cıl

10PUBLICATIONS
62CO-AUTHORS
Haematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)HaematologyComparative language studies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 10, 2026
Baseline ALBI Grade as an Independent Prognostic Factor of Survival in High-Risk Real-World HCC Under Atezolizumab-Bevacizumab.

|Dec 30, 2025
Prognostic Value of CONUT and ALBI in Metastatic Pancreatic Cancer: A Retrospective Cohort Study.

Pınar Peker, Aslı Geçgel, Serdar Yılmaz

|Oct 31, 2025
Dynamics of body composition in the treatment of locally advanced rectal cancer: the ımpact of adipose and muscle tissue on pathological response.

Okan Dilek, Emin Demırel, Berkay Eyı

|Sep 27, 2025
Systemic Immune-Inflammation Index as a Prognostic Marker in Gastric and Gastroesophageal Junction Cancers Receiving Perioperative FLOT Therapy.

Pinar Peker, Asli Geçgel, Oğuzcan Özkan

|Jun 18, 2025
Importance of 18F-fluorodeoxyglucose positron emission tomography/computed tomography heterogeneity indices in non-small cell lung cancer.

Ali Ogul, Ilhan Birsenogul, Aygul Polat Kelle

|May 06, 2025
The impact of carboplatin on pathologic complete response and survival based on HER2 low and HER2 zero status in triple negative breast cancer patients receiving neoadjuvant chemotherapy: a multicenter real-world analysis.

Sedat Yıldırım, Tugba Başoğlu, Akif Doğan

Pageof 2

Frequent Collaborators

4 joint publications

Berna Bozkurt Duman

2 joint publications

Serdar Ata

2 joint publications

Okan Dilek

2 joint publications

Aslı Geçgel